Investigating the molecular drivers of high-level clinical responses to bimekizumab in psoriatic disease: Introducing the BE UNIQUE phase 3b study.

Bimzelx (bimekizumab-bkzx) - UCB

http://www.ncbi.nlm.nih.gov/pubmed/42678333

Ann Cleverly; Balint Szilagyi; Christiane Simon-Hinsberg; Iain B McInnes; Ioana Cutcutache; James G Krueger; Joe Rastrick; Johann E Gudjonsson; Joseph F Merola; Paul Jones; Richard B Warren

Sep 2, 2026